Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias

Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4256-61. doi: 10.1073/pnas.070029997.

Abstract

High mobility group I (HMGI) proteins are overexpressed in several human malignant tumors. We previously demonstrated that inhibition of HMGI synthesis prevents thyroid cell transformation. Here, we report that an adenovirus carrying the HMGI(Y) gene in an antisense orientation (Ad-Yas) induced programmed cell death of two human thyroid anaplastic carcinoma cell lines (ARO and FB-1), but not normal thyroid cells. The Ad-Yas virus led to death of lung, colon, and breast carcinoma cells. A control adenovirus carrying the lacZ gene did not inhibit the growth of either normal or neoplastic cells. Ad-Yas treatment of tumors induced in athymic mice by ARO cells caused a drastic reduction in tumor size. Therefore, suppression of HMGI(Y) protein synthesis by an HMGI(Y) antisense adenoviral vector may be a useful treatment strategy in a variety of human malignant neoplasias, in which HMGI(Y) gene overexpression is a general event.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae / genetics*
  • Animals
  • Apoptosis / genetics
  • Base Sequence
  • Carcinoma / pathology
  • Carcinoma / therapy*
  • DNA Primers
  • Flow Cytometry
  • Genetic Therapy*
  • HMGA1a Protein
  • High Mobility Group Proteins / antagonists & inhibitors*
  • High Mobility Group Proteins / biosynthesis
  • High Mobility Group Proteins / genetics
  • Humans
  • Immunohistochemistry
  • Male
  • Mice
  • Mice, Nude
  • Oligonucleotides, Antisense / genetics
  • Thyroid Neoplasms / pathology
  • Thyroid Neoplasms / therapy*
  • Transcription Factors / antagonists & inhibitors*
  • Transcription Factors / biosynthesis
  • Transcription Factors / genetics
  • Tumor Cells, Cultured

Substances

  • DNA Primers
  • High Mobility Group Proteins
  • Oligonucleotides, Antisense
  • Transcription Factors
  • HMGA1a Protein